Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02481986 · ClinicalTrials.gov registry record · Phase 3
Asthma Action at Erie Trial
A Phase 3 study of Asthma and Children, sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- Phase 3
- Development phase
- 223
- Enrollment target
- 1
- Study location
NCT02481986 is a Phase 3 study of Asthma and Children that has completed, run by University of Illinois at Chicago. The registered enrollment target is 223 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02481986, a Phase 3 study of Asthma and Children, has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 223 participants
- Enrollment target
- 1
- Study location
Study Summary
The Asthma Action at Erie Trial compares the current best practice in asthma self-management education (certified asthma educator services) to an integrated community health worker (CHW) home intervention in which the real-life challenges of patients and the health care system are taken fully into account. This trial will provide clarity as to the expected effect size, cost savings, and resources needed to integrate asthma CHWs into clinical practice.
Interventions
- BEHAVIORAL Community Health Worker
- BEHAVIORAL Certified asthma educator
Study Locations (1)
Illinois
- Erie Family Health Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 223 participants |
| Start Date | 2015-04-01 |
| Est. Completion | 2021-03-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02481986
The ClinicalTrials.gov registry entry for NCT02481986 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 223 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (86% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Community Health Worker is the first listed.
NCT02481986 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT02481986 about?
NCT02481986 is a clinical study titled "Asthma Action at Erie Trial". The Asthma Action at Erie Trial compares the current best practice in asthma self-management education (certified asthma educator services) to an integrated community health worker (CHW) home intervention in which the real-life challenges of patients and the health care system are taken fully into a...
What is the current status of trial NCT02481986?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 223 participants. The study started on 2015-04-01. Estimated completion is 2021-03-31.
What conditions does trial NCT02481986 study?
This clinical trial studies the following conditions: Asthma, Children.
What interventions are being tested in trial NCT02481986?
The interventions under investigation include: Community Health Worker (BEHAVIORAL), Certified asthma educator (BEHAVIORAL).
Who is sponsoring clinical trial NCT02481986?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02481986 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
RECRUITING · Phase 3
-
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
RECRUITING · Phase 3
-
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
RECRUITING · Phase 3
-
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
RECRUITING · Phase 3
-
Efficacy and Safety of Subcutaneous Dupilumab in Participants With Asthma/Asthmatic Wheeze Aged 2 to <6 Years (LIBERTY ASTHMA TREKIDS)
RECRUITING · Phase 3
-
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.